Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prolonged complete remission in previously severe SLE

E C Tozman, M B Urowitz, D D Gladman

    Annals of the Rheumatic Diseases
    |February 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Declining levels of serum chemokine (C-X-C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker?

    The British journal of dermatology·2020
    Same author

    Disease course patterns in systemic lupus erythematosus.

    Lupus·2018
    Same author

    Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study.

    Arthritis research & therapy·2018
    Same author

    Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors.

    Lupus·2018
    Same author

    Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies.

    Lupus·2018
    Same author

    Antimalarial-induced cardiomyopathy: a systematic review of the literature.

    Lupus·2017
    Same journal

    Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

    Annals of the rheumatic diseases·2026
    Same journal

    A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus.

    Annals of the rheumatic diseases·2026
    Same journal

    PD-1 signalling restrains pathogenic T peripheral helper and effector CD4⁺ T cell functions in rheumatoid arthritis.

    Annals of the rheumatic diseases·2026
    Same journal

    Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma.

    Annals of the rheumatic diseases·2026
    Same journal

    Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project.

    Annals of the rheumatic diseases·2026
    Same journal

    Commentary on 'Assessing the performance of AI chatbots in answering patients common questions about low back pain'.

    Annals of the rheumatic diseases·2026
    See all related articles

    Four patients with severe systemic lupus erythematosus achieved complete remission without therapy for over six years. This long-term study highlights the potential for sustained remission in lupus patients.

    Area of Science:

    • Rheumatology
    • Immunology
    • Internal Medicine

    Background:

    • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
    • Severe SLE often requires long-term immunosuppressive therapy.
    • Predicting sustained remission in SLE remains a challenge.

    Purpose of the Study:

    • To report on long-term remission in patients with previously severe systemic lupus erythematosus.
    • To investigate remission duration and treatment requirements in a subset of SLE patients.

    Main Methods:

    • Prospective observational study of 160 SLE patients.
    • Analysis of patients achieving complete remission without maintenance therapy.
    • Tracking of remission duration and clinical/laboratory features.

    Related Experiment Videos

    Main Results:

    • Four out of 160 patients (2.5%) achieved complete remission.
    • These patients had previously severe SLE and no therapy for a median of 75 months.
    • Remission included both clinical and laboratory features of SLE.

    Conclusions:

    • Sustained, therapy-free remission is possible in a small proportion of severe SLE patients.
    • Early diagnosis and treatment, as seen in these female patients, may influence outcomes.
    • Further research is needed to understand the mechanisms and predictors of such remissions.